Clinical Trial

Troponin In Carotid Revascularization

Study acronym: TROPICAR
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Patients undergoing carotid revascularization procedures are at increased risk for the development of short- and long-term cardiac complications. Increased values of high-sensitive troponin may be useful in a timely selection of those patients. Still, contemporary literature doesn't provide enough data to answer the following questions: "Can high-sensitive troponin predict adverse cardiac outcomes perioperatively in carotid surgery?", "Should these cardiac biomarkers be routinely sampled in all patients undergoing carotid revascularization?" and "Can elevated levels of high-sensitive troponin preoperatively designate patients in whom the risk of surgical treatment (at a given moment) is greater than the benefit of the surgery?".
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-03-14; most recent amendment 2026-06-26.
Status change: Recruiting → Active, Not Recruiting 2023-10-01
Status change: Not Yet Recruiting → Recruiting 2023-01-20
Trial Details
NCT Number NCT05293067
Lead Sponsor University of Belgrade
Conditions Carotid Artery Stenosis
Enrollment 527 participants
Start Date 2023-06-01
Primary Completion 2024-10-01 (estimated)
Study Completion 2028-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-30